Xiuping Du
Overview
Explore the profile of Xiuping Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen L, Li Y, Zhang X, Du X, Zhang Y, Li X, et al.
Int J Biol Macromol
. 2024 Aug;
278(Pt 3):134186.
PMID: 39173790
Diabetic cognitive dysfunction (DCD) refers to cognitive impairment in individuals with diabetes, which is one of the most important comorbidities and complications. Preliminary evidence suggests that consuming sufficient dietary fiber...
2.
Chen Y, Lv G, Du X, Yang F, Zhao Z
Biol Pharm Bull
. 2023 Dec;
46(12):1797-1804.
PMID: 38044098
Gestational diabetes mellitus (GDM) is an important cause of the increase in incidence rate and mortality of pregnant women and perinatal infants. This study aimed to analyze the role of...
3.
Du L, Du X, Wang W, Hu L, Qiao C, Shi R
Rev Assoc Med Bras (1992)
. 2022 Nov;
68(12):1651-1656.
PMID: 36449788
Objective: The aim of this study was to explore the influencing factors of preterm twin pregnancy. Methods: In total, 602 twin-pregnant women delivered from February 2016 to February 2020 were...
4.
Li L, Shi G, Zhu L, Wang H, Zhang Z, Du X
Am J Transl Res
. 2022 Sep;
14(8):5931-5940.
PMID: 36105038
Objective: To investigate the efficacy of atosiban combined with ritodrine in threatened preterm labor (TPL) treatment and analysis of related risk factors of different pregnancy outcomes. Methods: A retrospective study...
5.
Wang H, Wu M, Liu H, Zhou H, Zhao Y, Geng Y, et al.
Front Oncol
. 2021 Dec;
11:785102.
PMID: 34900739
Background: The present COVID-19 pandemic has tended toward normality. To provide convenient, safe, and effective home treatment programs for patients with recurrent ovarian cancer (ROC), the clinical efficacy and safety...
6.
Wu X, Zhu J, Wang J, Lin Z, Yin R, Sun W, et al.
Clin Cancer Res
. 2021 Nov;
28(4):653-661.
PMID: 34844979
Purpose: Phase I results of this phase I/II study showed that pamiparib 60 mg twice a day had antitumor activity and an acceptable safety profile in Chinese patients with advanced...
7.
Zhao H, Yao W, Min X, Gu K, Yu G, Zhang Z, et al.
J Thorac Oncol
. 2021 May;
16(9):1533-1546.
PMID: 34033974
Introduction: Blocking vascular endothelial growth factor pathway can enhance the efficacy of EGFR tyrosine kinase inhibitors in EGFR-mutant NSCLC. ACTIVE is the first phase 3 study conducted in the People's...
8.
Kou T, Wang Q, Lv W, Wei B, Liu Y, Zhao S, et al.
Jpn J Infect Dis
. 2019 Mar;
72(4):243-249.
PMID: 30918145
A case-control study was conducted in Shandong from January to December 2017 to explore the relationship between sleep quality and the risk of active pulmonary tuberculosis (PTB). Seventy-nine patients with...
9.
Zhang L, Wang H, Li C, Zhao Y, Wu L, Du X, et al.
Cell Physiol Biochem
. 2017 Nov;
44(3):1251-1262.
PMID: 29179185
Background/aims: Targeting cancer stem cells (CSCs) is emerging as a promising method for cancer treatment. We previously indicated that knockdown of Neuropilin 1(NRP-1) could inhibit breast cancer cell proliferation. Here,...
10.
Han Z, Sun X, Jiang G, Du X
J Coll Physicians Surg Pak
. 2016 Dec;
26(11):900-903.
PMID: 27981924
Objective: To explore the efficacy and safety of thalidomide for the treatment of delayed vomiting, induced by chemotherapy in cancer patients. Study Design: Randomized, double-blind controlled study. Place And Duration...